Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (14)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Henriksson, G.
Right arrow Articles by Bredberg, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henriksson, G.
Right arrow Articles by Bredberg, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 142-147
© 2000 British Society for Rheumatology

Antibodies to CD4 in primary Sjögren's syndrome

G. Henriksson3, R. Manthorpe1 and A. Bredberg

Department of Medical Microbiology, University Hospital, Malmö and
1 Sjögren's Syndrome Research Centre, Department of Rheumatology, University Hospital, Malmö, Sweden

Objective. The purpose of this study was to examine whether antibodies against CD4 are present in patients with primary Sjögren's syndrome, and to explore the possible correlation between these antibodies and the CD4+ T lymphocyte depletion that is seen in some Sjögren patients.

Methods. Sera from 214 patients with primary Sjögren's syndrome, 154 healthy blood donors, 38 age- and sex-matched controls without autoimmune disease, and 77 HIV-1-seropositive individuals were analysed by an enzyme-linked immunosorbent assay (ELISA) using recombinant soluble CD4 as the antigen.

Results. Anti-CD4 antibodies were observed more frequently in patients with Sjögren's syndrome (12.6%) as compared with the control groups (0.6%) (P < 0.001), and at a level similar to that seen among the HIV-1 patients (13.0%). However, no correlation was found between the presence of anti-CD4 antibodies and CD4+ T lymphocytopenia in the Sjögren patients.

Conclusion. This is the first study that shows anti-CD4 antibodies in patients with primary Sjögren's syndrome. The significance of these antibodies in the immunopathogenesis of Sjögren's syndrome remains to be determined.

KEY WORDS: Anti-CD4 antibodies, Autoimmunity/autoantibodies, Sjögren's syndrome.

3 Correspondence to: G. Henriksson, Department of Medical Microbiology, University Hospital, S-205 02 Malmö, Sweden.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
A. Schattner, J. Friedman, and Z. Bentwich
Opportunistic infection due to unexplained CD4+ lymphocytopenia and associated Sjogren's syndrome
Rheumatology, January 1, 2004; 43(1): 111 - 112.
[Full Text] [PDF]


Home page
CVIHome page
L. Du, S. Fukushima, A. Sallmyr, R. Manthorpe, and A. Bredberg
Exposure of HEp-2 Cells to Stress Conditions Influences Antinuclear Antibody Reactivity
Clin. Vaccine Immunol., March 1, 2002; 9(2): 287 - 294.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
A. Klepfish, J. Friedman, Y. Schechter, and A. Schattner
Autoimmune neutropenia, thrombocytopenia and Coombs positivity in a patient with primary Sjogren's syndrome
Rheumatology, August 1, 2001; 40(8): 948 - 949.
[Full Text] [PDF]


Home page
QJMHome page
A. Schattner, J. Friedman, A. Klepfish, and A. Berrebi
Immune cytopenias as the presenting finding in primary Sjogren's syndrome
QJM, December 1, 2000; 93(12): 825 - 829.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.